Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples-Reference-Cited by-同舟云学术

Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples

Published:2019-03-20 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Halperin Rebecca F.,Liang Winnie S.,Kulkarni Sidharth,Tassone Erica E.,Adkins Jonathan,Enriquez Daniel,Tran Nhan L.,Hank Nicole C.,Newell James,Kodira Chinnappa,Korn Ronald,Berens Michael E.,Kim Seungchan,Byron Sara A.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference31 articles.

1. Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine;Allen;Nat Med.,2014

2. Comprehensive characterization of cancer driver genes and mutations;Bailey;Cell,2018

3. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology;Cheng;J Mol Diagn.,2015

4. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing;Frampton;Nat Biotechnol.,2013

5. Role of non-coding sequence variants in cancer;Khurana;Nat Rev Genet.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Genomics and Evolution;Holland‐Frei Cancer Medicine;2022-10-21

2. Combinatorial and Machine Learning Approaches for Improved Somatic Variant Calling From Formalin-Fixed Paraffin-Embedded Genome Sequence Data;Frontiers in Genetics;2022-04-27

3. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation;Frontiers in Oncology;2022-03-03

4. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion;Cancer Research;2021-10-05

5. UNMASC: tumor-only variant calling with unmatched normal controls;NAR Cancer;2021-10-04